List of works - Yaojun Zhang

18F-fluorodeoxyglucose positron emission tomography in management of pancreatic cystic tumors

scientific article published on 04 May 2012

A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy

scientific article published on 28 August 2013

A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma

scientific article

A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

scientific article

A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma

scientific article published on 27 September 2018

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.

scientific article published on 20 October 2015

Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib

scientific article published on June 2015

Assessing Hepatic Fibrosis Using 2-D Shear Wave Elastography in Patients with Liver Tumors: A Prospective Single-Center Study

scientific article published on 12 August 2017

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

scientific article published on 01 December 2020

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

scientific article published on 16 December 2020

Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.

scientific article published on 21 March 2016

Expert consensus on local ablation therapies for primary liver cancer

scientific article published on 01 September 2012

Family history of hepatocellulcar carcinoma is not associated with its patients' prognosis after hepatectomy.

scientific article published on 18 October 2013

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

scientific article

Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus

scientific article published on 22 February 2012

Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.

scientific article published on 15 April 2013

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy ⬇️

scientific article published on July 2, 2012

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.

scientific article

Higher dietary intakes of choline and betaine are associated with a lower risk of primary liver cancer: a case-control study.

scientific article

Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization

scientific article

Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization

scientific article published on May 2015

Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy

scientific article published on 04 March 2012

Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review

scientific article published on 11 December 2013

Long-term therapy with sorafenib is associated with pancreatic atrophy.

scientific article

Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration

scientific article

Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis

scientific article published on March 2016

Novel Percutaneous Radiofrequency Ablation of Portal Vein Tumor Thrombus: Safety and Feasibility ⬇️

scientific article published on August 2, 2012

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma

scientific article published on 25 August 2017

Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study

scientific article

Percutaneous microwave ablation of larger hepatocellular carcinoma.

scientific article published on 4 July 2012

Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation

scientific article published on 14 March 2013

Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: a meta-analysis.

scientific article published on 10 April 2012

Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

scientific article

Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: Long-term results ⬇️

scientific article published on September 16, 2010

Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study

scientific article published on 9 January 2017

Radiofrequency ablation does not induce the significant increase of CD4(+) CD25(+) Foxp3(+) regulatory T cells compared with surgical resection in Hepal-6 tumor model.

scientific article published on 18 April 2013

Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study

scientific article published on 01 March 2012

Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma.

scientific article published on 6 August 2013

Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.

scientific article published on 12 December 2011

Role of radiofrequency ablation in the treatment of hepatocellular carcinoma: experience of a cancer center in China

scientific article published on 22 December 2011

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study

scientific article published on 28 May 2020

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study

scientific article published on 05 August 2019

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma

scientific article

The Association between Dietary Vitamin A and Carotenes and the Risk of Primary Liver Cancer: A Case-Control Study

scientific article published on 11 October 2016

The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients

scientific article published on 27 July 2013

The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy

scientific article published on 18 February 2014

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.

scientific article published on 27 March 2018

The role of miR-10b in metastatic pancreatic ductal adenocarcinoma

scientific article published on 06 June 2012

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma

scientific article published on 16 September 2019

Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study

scientific article published on 14 September 2010

Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients

scientific article published on 25 August 2017

Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

scientific article published on 10 August 2012

[Hepatitis B reactivation after treatment for HBV-related hepatocellular carcinoma: comparative analysis of radiofrequency ablation versus hepatic resection]

scientific article published on 01 January 2014

List of works by Yaojun Zhang

18F-fluorodeoxyglucose positron emission tomography in management of pancreatic cystic tumors

A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy

A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma

A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.

Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib

Assessing Hepatic Fibrosis Using 2-D Shear Wave Elastography in Patients with Liver Tumors: A Prospective Single-Center Study

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.

Expert consensus on local ablation therapies for primary liver cancer

Family history of hepatocellulcar carcinoma is not associated with its patients' prognosis after hepatectomy.

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus

Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy ⬇️

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.

Higher dietary intakes of choline and betaine are associated with a lower risk of primary liver cancer: a case-control study.

Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization

Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization

Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy

Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review

Long-term therapy with sorafenib is associated with pancreatic atrophy.

Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration

Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis

Novel Percutaneous Radiofrequency Ablation of Portal Vein Tumor Thrombus: Safety and Feasibility ⬇️

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma

Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study

Percutaneous microwave ablation of larger hepatocellular carcinoma.

Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation

Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: a meta-analysis.

Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: Long-term results ⬇️

Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study

Radiofrequency ablation does not induce the significant increase of CD4(+) CD25(+) Foxp3(+) regulatory T cells compared with surgical resection in Hepal-6 tumor model.

Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study

Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma.

Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.

Role of radiofrequency ablation in the treatment of hepatocellular carcinoma: experience of a cancer center in China

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma

The Association between Dietary Vitamin A and Carotenes and the Risk of Primary Liver Cancer: A Case-Control Study

The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients

The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.

The role of miR-10b in metastatic pancreatic ductal adenocarcinoma

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma

Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study

Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients

Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

[Hepatitis B reactivation after treatment for HBV-related hepatocellular carcinoma: comparative analysis of radiofrequency ablation versus hepatic resection]